Howland Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35M Sell
69,813
-2,878
-4% -$1.38M 1.26% 19
2026
Q1
$35.8M Sell
72,691
-3,516
-5% -$1.91M 1.41% 19
2025
Q4
$44.2M Buy
76,207
+476
+0.6% +$269K 1.68% 17
2025
Q3
$36.8M Buy
75,731
+554
+0.7% +$258K 1.4% 21
2025
Q2
$30.5M Sell
75,177
-3,632
-5% -$1.52M 1.24% 25
2025
Q1
$39.2M Sell
78,809
-962
-1% -$521K 1.75% 17
2024
Q4
$41.5M Buy
79,771
+2,098
+3% +$1.15M 1.82% 15
2024
Q3
$48.1M Buy
77,673
+47
+0.1% +$27.8K 2.08% 13
2024
Q2
$43M Buy
77,626
+95
+0.1% +$54.4K 2.05% 14
2024
Q1
$45.1M Sell
77,531
-141
-0.2% -$79.1K 2.18% 11
2023
Q4
$41.3M Buy
77,672
+1,217
+2% +$589K 2.18% 11
2023
Q3
$38.7M Sell
76,455
-38
-0% -$20.2K 2.26% 10
2023
Q2
$39.9M Sell
76,493
-5,251
-6% -$2.83M 2.29% 10
2023
Q1
$47.1M Sell
81,744
-1,398
-2% -$788K 2.84% 5
2022
Q4
$45.8M Sell
83,142
-5,804
-7% -$3.08M 2.82% 5
2022
Q3
$45.1M Sell
88,946
-1,887
-2% -$1.06M 2.9% 5
2022
Q2
$49.4M Sell
90,833
-2,574
-3% -$1.42M 3.03% 5
2022
Q1
$55.2M Sell
93,407
-1,710
-2% -$982K 2.97% 5
2021
Q4
$63.5M Sell
95,117
-2,511
-3% -$1.57M 3.22% 3
2021
Q3
$55.8M Sell
97,628
-3,049
-3% -$1.67M 2.94% 4
2021
Q2
$50.8M Sell
100,677
-2,379
-2% -$1.12M 2.62% 8
2021
Q1
$47M Buy
103,056
+871
+0.9% +$416K 2.62% 8
2020
Q4
$47.6M Sell
102,185
-1,473
-1% -$691K 2.79% 6
2020
Q3
$45.8M Sell
103,658
-1,074
-1% -$444K 3.02% 6
2020
Q2
$37.9M Sell
104,732
-1,419
-1% -$476K 2.72% 6
2020
Q1
$30.1M Buy
106,151
+410
+0.4% +$129K 2.64% 7
2019
Q4
$34.4M Sell
105,741
-6,004
-5% -$1.82M 2.44% 6
2019
Q3
$32.5M Sell
111,745
-496
-0.4% -$142K 2.47% 7
2019
Q2
$33M Buy
112,241
+984
+0.9% +$271K 2.55% 7
2019
Q1
$30.5M Sell
111,257
-82
-0.1% -$20.4K 2.48% 7
2018
Q4
$24.9M Sell
111,339
-15,403
-12% -$3.61M 2.34% 6
2018
Q3
$30.9M Sell
126,742
-1,369
-1% -$315K 2.35% 5
2018
Q2
$26.5M Sell
128,111
-5,523
-4% -$1.17M 2.12% 6
2018
Q1
$27.6M Sell
133,634
-1,184
-0.9% -$249K 2.22% 7
2017
Q4
$25.6M Sell
134,818
-1,465
-1% -$281K 2.05% 10
2017
Q3
$25.8M Buy
136,283
+560
+0.4% +$101K 2.13% 10
2017
Q2
$23.7M Sell
135,723
-471
-0.3% -$79.1K 2% 12
2017
Q1
$20.9M Buy
136,194
+187
+0.1% +$28.6K 1.81% 15
2016
Q4
$19.2M Buy
136,007
+775
+0.6% +$114K 1.79% 16
2016
Q3
$21.5M Buy
135,232
+737
+0.5% +$114K 2% 12
2016
Q2
$19.9M Buy
134,495
+10,029
+8% +$1.48M 1.87% 17
2016
Q1
$17.6M Buy
124,466
+5,529
+5% +$741K 1.79% 15
2015
Q4
$16.9M Buy
118,937
+15,822
+15% +$2.11M 1.71% 16
2015
Q3
$12.6M Buy
103,115
+955
+0.9% +$124K 1.37% 28
2015
Q2
$13.3M Buy
102,160
+703
+0.7% +$91.6K 1.36% 29
2015
Q1
$13.6M Sell
101,457
-1,336
-1% -$172K 1.39% 33
2014
Q4
$12.9M Sell
102,793
-3,255
-3% -$396K 1.28% 34
2014
Q3
$12.9M Sell
106,048
-7,016
-6% -$853K 1.33% 33
2014
Q2
$13.3M Buy
113,064
+4,055
+4% +$477K 1.36% 31
2014
Q1
$13.1M Buy
109,009
+7,713
+8% +$917K 1.49% 25
2013
Q4
$11.3M Sell
101,296
-4,805
-5% -$478K 1.4% 27
2013
Q3
$9.78M Sell
106,101
-504
-0.5% -$45.6K 1.33% 29
2013
Q2
$9.02M Buy
+106,605
New +$8.87M 1.43% 26

Other funds holding TMO

Howland Capital Management's TMO Position: Q2 2026 in Review

Howland Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 4% in Q2 2026, selling an estimated $1.38M and leaving 69,813 shares worth $35M. The position accounts for 1.26% of the portfolio, ranked #19.

Howland Capital Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $63.5M in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Howland Capital Management held 69,813 shares of Thermo Fisher Scientific worth $35M as of Q2 2026.
  • Howland Capital Management sold 2,878 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.38M.
  • Thermo Fisher Scientific made up 1.26% of Howland Capital Management's portfolio in Q2 2026, its #19 holding.
  • Howland Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Howland Capital Management's Thermo Fisher Scientific position peaked at $63.5M in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Howland Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.